Skip to main content
Clinical Trials/CTRI/2013/02/003432
CTRI/2013/02/003432
Recruiting
Phase 3

A RANDOMIZED SINGLE BLIND CLINICAL TRIAL TO COMPARE THE ERADICATION RATE, PREVENTION OF ULCER RECURRENCE,SIDE EFFECT, PATIENT COMPLIANCE AND COST EFFECTIVENESS OF SEQUENTIAL VERSUS NON- BISMUTH CONCOMITANT QUADRUPLE THERAPY fOR TREATMENT OF HELICOBACTER PYLORI IN PATIENTS WITH PERFORATED DUODENAL ULCER

JIPMER0 sites80 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
JIPMER
Enrollment
80
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Interventional

Investigators

Sponsor
JIPMER

Eligibility Criteria

Inclusion Criteria

  • ALL CONSECUTIVE PATIENTS AGED MORE THAN 18 YEARS WITH PERFORATED DUODENAL ULCER FOLLOWING SIMPLE CLOSURE WITH H. PYLORI INFECTIO

Exclusion Criteria

  • 1\. GASTRIC ULCER PERFORATION
  • 2\. PATIENTS UNDERGOING ANY OTHER PROCEDURE APART FROM THE SIMPLE CLOSURE FOR PERFORATED DUODENAL ULCER.
  • 3\. PATIENTS WITH ASSOCIATED UPPER GI DISORDERS.
  • 4\. PATIENTS PRESENTING WITH REPERFORATION OR OTHER COMPLICATIONS.

Outcomes

Primary Outcomes

Not specified

Similar Trials